Last reviewed · How we verify
intravenous application of tranexamic acid
intravenous application of tranexamic acid is a Small molecule drug developed by Chang Gung Memorial Hospital. It is currently FDA-approved. Also known as: transamine.
Intravenous tranexamic acid, marketed by Chang Gung Memorial Hospital, holds a position in the antifibrinolytic market with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established mechanism and clinical efficacy, which supports its current market presence. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | intravenous application of tranexamic acid |
|---|---|
| Also known as | transamine |
| Sponsor | Chang Gung Memorial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery (EARLY_PHASE1)
- Effect of Intravenous and Topical Tranexamic Acid on Drain Output in Breast Reduction Surgery (PHASE4)
- Intravenous Tranexamic Acid (NA)
- Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients (PHASE1, PHASE2)
- Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa (NA)
- Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery (EARLY_PHASE1)
- Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation (PHASE4)
- Enhanced Recovery After Surgery (ERAS) Pathway for Primary Hip and Knee Arthroplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intravenous application of tranexamic acid CI brief — competitive landscape report
- intravenous application of tranexamic acid updates RSS · CI watch RSS
- Chang Gung Memorial Hospital portfolio CI
Frequently asked questions about intravenous application of tranexamic acid
What is intravenous application of tranexamic acid?
Who makes intravenous application of tranexamic acid?
Is intravenous application of tranexamic acid also known as anything else?
What development phase is intravenous application of tranexamic acid in?
Related
- Manufacturer: Chang Gung Memorial Hospital — full pipeline
- Also known as: transamine
- Compare: intravenous application of tranexamic acid vs similar drugs
- Pricing: intravenous application of tranexamic acid cost, discount & access